GSK
What one share of GSK holds
Pharmaceutical Preparations
GSK is a global biopharma group which prevents and treats disease with specialty medicines, vaccines and general medicines. GSK focuses on the science of the immune system and advanced technologies, investing in four core therapeutic areas: respiratory, immunology and inflammation; oncology;
GSK’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $20.93 |
|---|---|
| Profit | $3.66 |
| Capex (buildings and equipment) | $0.86 |
| Free cash flow | $4.10 |
| Dividends | $1.64 |
| Cash and investments | $2.12 |
| Debt | $9.01 |
| Book value | $10.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $15.40 | $0.50 | $0.85 | $2.74 | — | $0.57 |
| 2017 | $15.75 | $0.80 | $0.81 | $2.80 | — | −$0.03 |
| 2018 | $16.57 | $1.95 | $0.72 | $3.80 | — | $1.79 |
| 2019 | $17.18 | $2.36 | $0.64 | $3.44 | — | $5.62 |
| 2020 | $15.51 | $3.66 | $0.63 | $4.74 | — | $7.40 |
| 2021 | $16.78 | $2.98 | $0.65 | $4.76 | — | $7.55 |
| 2022 | $17.77 | $9.06 | $0.69 | $3.79 | — | $5.94 |
| 2023 | $18.35 | $2.98 | $0.80 | $3.30 | — | $7.89 |
| 2024 | $19.36 | $1.59 | $0.86 | $3.18 | — | $7.93 |
| 2025 | $20.93 | $3.66 | $0.86 | $4.10 | — | $10.21 |